FDA 483 - STAQ Pharma, Inc. - September 03, 2020

STAQ Pharma, Inc. in Denver, CO, an outsourcing facility, received an FDA Form 483 citing multiple deficiencies. These included inadequate investigations into product discrepancies, insufficient aseptic process validation, and poor environmental monitoring. Additionally, issues with cleaning procedures and deficient drug product labeling were noted.